The end of hypoallergenic cats?

A controversial company that claimed to develop hypoallergenic cats and dogs will bow out of the companion animal business and launch a new venture focused on veterinary diagnostic services starting next year, according to a statement sent out in their corporate newsletter this Sunday (29th November). Image: Wikimedia Commons"Following our recent acquisition, the business will be taking a new direction from 2010, specifically, fine-tuning and launching our proprietary veterinary genetic molecul

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
A controversial company that claimed to develop hypoallergenic cats and dogs will bow out of the companion animal business and launch a new venture focused on veterinary diagnostic services starting next year, according to a statement sent out in their corporate newsletter this Sunday (29th November).
Image: Wikimedia Commons
"Following our recent acquisition, the business will be taking a new direction from 2010, specifically, fine-tuning and launching our proprietary veterinary genetic molecular diagnostic products," reads a statement from the company, called Allerca Lifestyle Pets. The statement did not indicate which company had acquired it, but noted that this information, as well as details on its new business model, will be announced publicly early next year. Allerca said that it will stop taking new orders for its two breeds of hypoallergenic cats and one dog breed as of December 31, 2010, but will continue filling already-placed orders through 2010 and early 2011. Allerca has been fraught with controversy ever since its 2004 launch. When __The Scientist__ linkurl:investigated;http://www.the-scientist.com/article/home/39383/ Allerca's claimed production of a hypoallergenic cat in late 2006, founder Simon Brodie evaded being interviewed at the company's Southern California headquarters, canceling several appointments with little advance notice. The inquiry and other previous investigations did reveal, though, that Brodie had been sued many times for failing to pay rent, failing to deliver pets to customers who paid hefty deposits, and other alleged offenses both before and after he started the company. In the 1990's Brodie was sentenced to two-and-a-half years in jail for false accounting in his native England. Allerca's cats and supposedly satisfied customers did, however, appear on national television shows, and the cats, which Allerca claimed were bred to have modified versions of a particular allergenic protein -- Fel d 1 -- were purportedly delivered to several people, at a cost of up to $22,000 per animal. In Sunday's statement, Allerca claims to have supplied "hundreds of clients" with hypoallergenic dogs and cats. The company's linkurl:website;http://www.allerca.com/html/catallergies.html lists approximately 20 supposed testimonials from customers who claim to have received hypoallergenic pets. However, Allerca published no scientific proof that their pets are in fact hypoallergenic, and subsequent investigations conducted by __The Scientist__ found several disappointed customers who were essentially told that they were linkurl:too allergic;http://www.the-scientist.com/blog/display/53265/ to receive Allerca cats. Then in January last year, Dutch authorities linkurl:seized;http://legacy.signonsandiego.com/uniontrib/20080205/news_1b5cats.html three of Allerca's "Ashera" cats and a Pennsylvania breeder claimed that the cats were in fact Savannah's (a pricey, but allergenic, breed) that were purchased from his facility. Dissatisfied customers have also posted linkurl:several;http://consumerist.com/2009/04/allerca-wheres-my-4000-hypoallergenic-cat.html linkurl:blogs;http://www.worldlawdirect.com/forum/money-frauds-scams/28122-simon-brodie-allerca-lifestyle-pets-fraud-carradan-skis.html scattered across the internet complaining that they paid for their pet from Allerca but never received it or their money back. At least two blogs -- linkurl:__Allerca Lifestyle Pet Rip-Off__;http://www.lifestylepets-ripoff.com/index.html and linkurl:__Is Allerca a Scam?__;http://allercascam.blogspot.com/ -- are devoted entirely to the issue. In Sunday's statement, the company hinted that its cat and dog days might not be over. "There is a slight possibility that a third party may license the hypoallergenic side of the business and the business is in discussion with various interested parties. Should a licensing agreement complete, we will make a further public announcement," the statement reads. The company did not respond to calls and an email asking for comment.
**__Related stories:__***linkurl:Is Murray hypoallergenic?;http://www.the-scientist.com/2009/06/1/21/1/
[June 2009]*linkurl:A wild cat chase;http://www.the-scientist.com/blog/display/54945/
[25th August 2008]*linkurl:Cat trouble brewing;http://www.the-scientist.com/blog/display/54020/
[4th December 2007]*linkurl:Felis Enigmaticus;http://www.the-scientist.com/article/display/39383/
[January 2007]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems